Schlack, K.; Krabbe, L.-M.; Fobker, M.; Schrader, A.J.; Semjonow, A.; Boegemann, M.
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer. Int. J. Mol. Sci. 2016, 17, 1520.
https://doi.org/10.3390/ijms17091520
AMA Style
Schlack K, Krabbe L-M, Fobker M, Schrader AJ, Semjonow A, Boegemann M.
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer. International Journal of Molecular Sciences. 2016; 17(9):1520.
https://doi.org/10.3390/ijms17091520
Chicago/Turabian Style
Schlack, Katrin, Laura-Maria Krabbe, Manfred Fobker, Andres Jan Schrader, Axel Semjonow, and Martin Boegemann.
2016. "Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer" International Journal of Molecular Sciences 17, no. 9: 1520.
https://doi.org/10.3390/ijms17091520
APA Style
Schlack, K., Krabbe, L.-M., Fobker, M., Schrader, A. J., Semjonow, A., & Boegemann, M.
(2016). Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer. International Journal of Molecular Sciences, 17(9), 1520.
https://doi.org/10.3390/ijms17091520